Perioperative Aspirin Usage Survey

Surgery Clinical Trial

Official title:

Use of Aspirin in the Perioperative Setting: A Surgeon's Survey

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02561507
• Other study ID #: 15-215
• Status: Terminated
• Start date: October 2015
• Est. completion date: May 2016

Study information

• Verified date: January 2024
• Source: University of New Mexico
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a survey of members of the American College of Surgeons (ACS), to describe and explore current patterns of their decisions about withholding or continuation for patients taking aspirin (ASA) in the perioperative period. Secondarily, the survey will also explore surgeons' knowledge about the risks and benefits attending this decision, and about national organizations' recommendations.

Description:

An announcement of the survey and invitation to participate will be posted in the "ACS Surgery News" newsletter published by the American College of Surgeons. Surgeons of all specialties will be invited to participate. No identifiers will be maintained with survey responses. In addition to the substantive questions below, typical demographic data will be obtained including participants' duration of practice, specialty, gender, state, etc.

The survey will include questions intended to characterize current practice surrounding the decision to continue or withhold aspirin in the perioperative period. Other questions will focus on surgeons' knowledge of national medical/surgical organizations that have published guidelines on the perioperative use of aspirin. Finally, other survey questions will characterize surgeons' knowledge of the platelet rebound effect.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 150
• Est. completion date: May 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Members of the American College of Surgeons

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Cardiovascular Disease
• Cardiovascular Diseases
• Surgery

Intervention

Behavioral:
• Survey

Locations

Country	Name	City	State
United States	University of New Mexico Hospital	Albuquerque	New Mexico

Sponsors (1)

Lead Sponsor	Collaborator
University of New Mexico

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Typical proportion of participants' patients given a recommendation to stop taking aspirin		At time of survey; generally less than 20 minutes
Primary	Proportion of participants correctly identifying national organizations with perioperative aspirin recommendations		At time of survey; generally less than 20 minutes
Primary	Proportion of participants correctly answering questions about platelet rebound effect		At time of survey; generally less than 20 minutes